bf/NASDAQ:HOOK_icon.jpeg

NASDAQ:HOOK

HOOKIPA Pharma Inc.

  • Stock

USD

Last Close

0.88

08/08 19:48

Market Cap

531.03M

Beta: 0.82

Volume Today

1.26M

Avg: 433.92K

PE Ratio

−0.77

PFCF: −1.39

    Description

    HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-pos...Show More

    Earnings

    Earnings per Share (Estimate*)

    -10-8-6-4-22018-03-302019-05-202021-05-122023-05-112024-11-07

    Revenue (Estimate*)

    2M4M6M8M10M12M2018-03-302019-05-202021-05-122023-05-112024-11-07

    *Estimate based on analyst consensus